Jim Cramer - Mad Money Cassava Sciences SAVA-Q DON'T BUY Jun 02, 2023

It loses a lot of money. Can't recommend any of those companies.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$23.040

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

RISKY

If they produce a big drug, shares can triple, but if they don't, then shares drift down. He likes the risk/reward ratio.

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Keith Richards

ValueTrend Wealth Management

Stockchase Insights

5i Research

Ryan Bushell

Newhaven Asset Management

David Burrows

Barometer Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money Cassava Sciences SAVA-Q DON'T BUY Jun 02, 2023

You might be interested:

Cassava Sciences(SAVA-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals